Patterns of Vitamin D Levels and Exposures in Active and Inactive Noninfectious Uveitis Patients
- 1 February 2020
- journal article
- conference paper
- Published by Elsevier in Ophthalmology
- Vol. 127 (2) , 230-237
Abstract
No abstract availableKeywords
Funding Information
- The Alfred Hospital (Y3158)
- National Health and Medical Research Council (GNT 1109330)
- Centre for Eye Research Australia
- Australian Government
This publication has 29 references indexed in Scilit:
- Novel pebbles in the mosaic of autoimmunityBMC Medicine, 2013
- Determinants of plasma 25-hydroxyvitamin D and development of prediction models in three US cohortsBritish Journal of Nutrition, 2012
- A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosisNeurology, 2011
- Randomized Comparison of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Implant for Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment TrialOphthalmology, 2011
- Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosisAnnals of Neurology, 2010
- A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosisNeurology, 2010
- The Multicenter Uveitis Steroid Treatment Trial: Rationale, Design, and Baseline CharacteristicsAmerican Journal of Ophthalmology, 2010
- Calcitriol Suppresses Antiretinal Autoimmunity through Inhibitory Effects on the Th17 Effector ResponseThe Journal of Immunology, 2009
- Anterior uveitis in murine relapsing experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS)Current Eye Research, 2000
- Aging decreases the capacity of human skin to produce vitamin D3.Journal of Clinical Investigation, 1985